Drug maker Eli Lilly is making a bet on rising global demand for animal drugs and vaccines with a deal to acquire Novartis AG's animal-health business for $5.4 billion.
from WSJ.com: US Business http://ift.tt/1tybU2Q
via IFTTT
from WSJ.com: US Business http://ift.tt/1tybU2Q
via IFTTT
No comments:
Post a Comment